Twenty years have passed since Congress mandated that NIH research include minorities. However, a recent study published by EMPaCT researcher Moon Chen, MD, and researchers at UC Davis found that less than 5% of clinical trial participants are non-white and less than 2% of clinical cancer research studies are on non-white ethnic or racial groups.
“The proportion of minorities in clinical research remains very low and is not representative of the U.S. population with cancer. What is needed is deliberate effort. Minorities are not hard to reach. They are hardly reached,” Dr. Chen was quoted as saying in US News & World Report.